Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Evaxion Biotech Q4 EPS $(0.39) Down From $(0.27) YoY

Evaxion Biotech (NASDAQ:EVAX) reported quarterly losses of $(0.39) per share. This is a 44.44 percent decrease over losses of $(0.27) per share from the same period last year.
byBill Haddad
March 22, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Evaxion Biotech (NASDAQ:EVAX) reported quarterly losses of $(0.39) per share. This is a 44.44 percent decrease over losses of $(0.27) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts